Turning Point Therapeutics, Inc.

TPTX · NASDAQ
Analyze with AI
6/30/2022
3/31/2022
12/31/2021
9/30/2021
Operating Activities
Net Income-$123-$74-$78-$66
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$17$15$14$14
Change in WC-$1-$1$8$8
Other Non-Cash$1$1$1$1
Operating Cash Flow-$105-$58-$54-$42
Investing Activities
PP&E Inv.-$2-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$30-$135-$48-$136
Inv. Sales/Matur.$108$75$123$154
Other Inv. Act.$0$0$0$0
Investing Cash Flow$77-$60$75$17
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$9$0$14$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$3$2
Financing Cash Flow$9$0$3$2
Forex Effect$0$0$0$0
Net Chg. in Cash-$19-$118$24-$22
Supplemental Information
Beg. Cash$311$430$406$428
End Cash$292$311$430$406
Free Cash Flow-$107-$59-$55-$43